Plain-English translation of NCT07802769 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is following people who participated in a previous glaucoma research project (called ENVOL) to see how the disease progresses over time. Researchers will use advanced brain imaging (MRI scans) to look at how glaucoma affects not just the eyes, but the entire visual pathway and brain structure. By comparing brain scans taken 10 years apart, scientists hope to better understand how glaucoma damages the brain and why people with glaucoma have a higher risk of developing other brain diseases like Alzheimer's.
Glaucoma is often thought of as an eye disease, but recent research shows it affects the entire brain's visual system. This study exists to understand the full scope of how this medication-resistant disease damages the brain over time, which could eventually lead to better treatments and earlier detection of brain-related complications.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital for comprehensive eye testing, including vision checks, eye pressure measurement, and imaging of your optic nerve. You'll also answer questions about your medical history and lifestyle. Then you'll undergo a brain MRI scan that takes detailed pictures of your brain's structure and activity while you rest. The whole visit takes several hours. Since this is a follow-up study comparing your results to scans from 10 years ago, the key is seeing how things have changed over that decade.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
France
Sponsor
University Hospital, Bordeaux
Enrollment target
~100 participants
Started
August 2026
Primary completion
May 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cedrick Schweitzer, MD, PhD
University Hospital, Bordeaux
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.